Bringing life-saving cancer care to patients in the developing world is a large unmet need, and every year, many lives are lost unnecessarily. Accurate and timely pathology services are a critical component of providing effective cancer care, determining both diagnosis and optimal treatment. This is particularly true for breast cancer, one of the leading causes of cancer death in the developing world. This project supports the development of pathology capacity in Rwanda, and assesses its quality and timeliness at a facility providing national referral pathology services, and can service as a road map for others to develop pathology capacity in other resource-limited settings.
Dr. Tharcisse Mpunga, Director of Butaro Hospital in Northern Rwanda, holds a degree in General Medicine, and is currently enrolled in a Master’s program in Applied Epidemiology at the National University of Rwanda. He has 10 years of experience in leadership and has been involved in many activities related to improving health indicators in Rwanda directed toward achieving the Millennium development Goals at the District and National level. He is Chairman of District Pharmacy Board of Directors, working on improving the drug supply chain in the health system. Together with Partners In Health and the Dana-Farber Cancer Institute, he has helped lead the development of the first center of Cancer Care Excellence in rural Rwanda at Butaro Hospital. He is currently involved in research related to cancer and non-communicable diseases (NCDs) in general.